Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336877 · ClinicalTrials.gov registry record
Aveir VR Coverage With Evidence Development Post-Approval Study
A clinical trial of Bradycardia and Arrythmia, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 8,744
- Enrollment target
- 1
- Study location
NCT05336877 is a study of Bradycardia and Arrythmia that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 8,744 participants, above the 4,111-participant average among 29 other Bradycardia trials with a reported enrollment target (113% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05336877, a study of Bradycardia and Arrythmia, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 8,744 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).
Conditions Studied
Interventions
- DEVICE Aveir VR Leadless Pacemaker System
- DEVICE Single-Chamber Transvenous Pacemaker
Study Locations (1)
California
- Abbott - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,744 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2028-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05336877
The ClinicalTrials.gov registry entry for NCT05336877 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,744 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,111-participant average among 29 other Bradycardia trials with a reported enrollment target (113% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 2 interventions - of which Aveir VR Leadless Pacemaker System is the first listed.
NCT05336877 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05336877 about?
NCT05336877 is a clinical study titled "Aveir VR Coverage With Evidence Development Post-Approval Study". The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).
What is the current status of trial NCT05336877?
This trial is currently recruiting. The enrollment target is 8,744 participants. The study started on 2022-06-21. Estimated completion is 2028-01-01.
What conditions does trial NCT05336877 study?
This clinical trial studies the following conditions: Bradycardia, Arrythmia, Cardiac Pacemaker.
What interventions are being tested in trial NCT05336877?
The interventions under investigation include: Aveir VR Leadless Pacemaker System (DEVICE), Single-Chamber Transvenous Pacemaker (DEVICE).
Who is sponsoring clinical trial NCT05336877?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05336877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.